Abstract:OBJECTIVE To investigate the stability of finished infusion after the compatibility of commonly used Shenmai, Xuebijing and Shenfu injection with commonly used clinical solvents, in order to provide technical guidance for safe and rational drug use in clinical practice. METHODS According to the general technical requirements of Chinese Pharmacopoeia 2020 edition, Shenmai, Xuebijing and Shenfu injection were mixed with different solvents to prepare the infusion solution of clinical common concentration. The samples were taken at 0,2,4,6,8,12,24 hours to investigate the pH value, Osmotic pressure and the number of insoluble particles. RESULTS（1）pH value: Within 0～24 hours, the pH values of Shenmai, Xuebijing and Shenfu injections mixed with different solvents ranged from 4.03 to 8.98,which were close to the human pH value（5～8）. The pH values of each diluted solution did not change much with time. Compared with the pH value at 0 hour, the changes were all less than 1.（2）Osmolarity: Within 0～24 hours, the osmotic pressure of Shenmai, Xuebijing and Shenfu injection combined with 0.9% sodium chloride injection and 5% glucose injection ranged from 278～311 mOsmol·kg -1 ,which were close to the human plasma osmotic pressure(280～310 mOsmol·kg -1 ).The Osmolarity of each diluted solution did not change much over time.（3）Insoluble particles: Within 0～2 hours the number of insoluble particles ≥10 μm were less than 25 and the number of insoluble particles ≥25 μm were less than 3 in the diluted drug solution of Shenmai injection after compatibility with 0.9% NS and 5% glucose, Xuebijing injection after compatibility with 0.9% NS,5% glucose and 10% glucose injection. Within 0～4 hours the number of insoluble particles ≥10 μm were less than 25 and the number of insoluble particles ≥25 μm were less than 3 in the diluted drug solution of Shenfu injection after compatibility with 5% glucose and 10% glucose. With the passage of time, the number of two kinds of insoluble particles in the infusion of the above finished products increased, and one of them did not meet the requirements of pharmacopoeia.With the passage of time, the number of insoluble particles increased, which did not meet the requirements of pharmacopoeia.CONCLUSIONS Shenmai injection should be diluted in 0.9%NS or 5% glucose injection for intravenous drip fluid, Xuebijing injection appropriate chooses 0.9% NS or 5% glucose as a solvent; Shenfu injection diluted to 5% glucose. In terms of the time limit for infusion of finished products of the above 3 drugs, Shenmai and Xuebijing injection should be used within 2 hours as far as possible; Shenfu injection should be used within 4 hours.

Study on Stability of Omeprazole for Injection

Preparation and Stability Investigation of Ibuprofen Injection

Study on the Compatible Stability of Ondansetron Hydrochloride Injection and Carboplatin for Injection

Could the Change of Excipient Content Improve the Stability of Gastroresistant Omeprazole Pellets?

Long-term Stability of Esomeprazole in 5% Dextrose Infusion Polyolefin Bags at 5 degrees C +/- 3 degrees C after Microwave Freeze-thaw Treatment

Preparation of Omeprazole Gastric Immediate Release Tablets and Study on the Formulation Thereof

Study on the Stability of Butorphanol Tartrate Injections in 0.9%Sodium Chloride Injections

Stability Study of Epirubicin Hydrochloride Solutions for Injection Prepared From Three Different Formulations

Study on the stability of traditional Chinese medicine injections mixed with different solvents in a hospital

Study on the stability of Amoxicillin Sodium and Flucloxacillin Sodium for injection in infusion solutions

Development of an Omeprazole Parenteral Formulation with Hydroxypropyl-β-Cyclodextrin

Investigation on the compatible stability of sodium tanshinone ⅡA sulfonate injection with 10 different drugs

Stability of rabeprazole sodium injection produced by different manufacturers after dispensation as an intravenous fluid

Combination Stability of Phloroglucinol Injection with 10 Clinical Injections

Study on Stability of Formestane for Injection

Stability of compatibility of oxiracetam for injection with four kinds of infusions

Study on Compatible Stability of Xiao'aiping Injection Combined with 3 Kinds of Injections

Stability Study of the Sample Solution Using for the Measurement of Related Substance in Raberprazole Sodium

Simultaneous Quantitative Analysis of Six Proton-Pump Inhibitors with a Single Marker and Evaluation of Stability of Investigated Drugs in Polypropylene Syringes for Continuous Infusion Use.

Studies on stability of doxycycline hydrochloride injection

Stability of Minocycline Hydrochloride for Injection Mixed with Common Infusion Solutions